Vertex Pharmaceuticals CEO on non-opioid painkiller: It's safe, effective and non-addictive
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The Sentinel49m
FDA Approves Journavx: A New Non-Opioid Pain Relief Solution for Millions
This category includes pain that can pop up due to injuries, following surgeries, or as a symptom of an illness. What makes Journavx different is its unique way of working; instead of acting on the ...
Barchart on MSN54m
Stocks Climb on Apple Earnings Results and Benign US Inflation News
Stocks have support on better-than-expected stock earnings news. Apple is up more than +2% after forecasting a ...
California Healthline31m
California Healthline Daily Edition
Below, check out the roundup of California Healthline's coverage. For today's national health news, read KFF Health News' Morning Briefing.